Novartis hit by China, emerging market slowdown: CEO on CNBC

ZURICH (Reuters) - Drugmaker Novartis has been hit by a slowdown in emerging markets, particularly in China, where previously double-digit growth has decelerated to mid-single digits, Chief Executive Joe Jimenez said in an interview with CNBC on Friday.